NASDAQ: ALTO
Alto Ingredients Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their ALTO stock forecasts and price targets.

Forecast return on equity

Is ALTO forecast to generate an efficient return?

Company
-1.77%
Industry
28.1%
Market
328.57%
ALTO's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is ALTO forecast to generate an efficient return on assets?

Company
-1.02%
Industry
9.17%
ALTO is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALTO earnings per share forecast

What is ALTO's earnings per share in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
-$0.41
Avg 2 year Forecast
-$0.05

ALTO revenue forecast

What is ALTO's revenue in the next 2 years based on estimates from 4 analysts?

Avg 1 year Forecast
$938.3M+1.74%
Avg 2 year Forecast
$1.0B+9.4%
ALTO's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALTO revenue growth forecast

How is ALTO forecast to perform vs Specialty Chemicals companies and vs the US market?

Company
1.74%
Industry
10.44%
Market
1,444.25%
ALTO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALTO's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALTO vs Specialty Chemical Stocks

TickerPricePrice TargetUp/downsideConsensus
ALTO$2.55N/AN/A
CMT$18.90N/AN/A
FF$3.30N/AN/A
OEC$5.08$7.00+37.80%Sell
HDSN$6.80$9.50+39.71%Strong Buy

Alto Ingredients Stock Forecast FAQ

What is ALTO's earnings growth forecast for 2025-2026?

(NASDAQ: ALTO) Alto Ingredients's forecast annual earnings growth rate of N/A is not forecast to beat the US Specialty Chemicals industry's average forecast earnings growth rate of 40.13%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 2,927.49%.

Alto Ingredients's earnings in 2025 is -$51,445,000.On average, 4 Wall Street analysts forecast ALTO's earnings for 2025 to be -$31,555,735, with the lowest ALTO earnings forecast at -$32,592,124, and the highest ALTO earnings forecast at -$30,047,557.

In 2026, ALTO is forecast to generate -$3,944,467 in earnings, with the lowest earnings forecast at -$19,706,866 and the highest earnings forecast at $12,993,538.

If you're new to stock investing, here's how to buy Alto Ingredients stock.

What is ALTO's revenue growth forecast for 2025-2026?

(NASDAQ: ALTO) Alto Ingredients's forecast annual revenue growth rate of 1.74% is not forecast to beat the US Specialty Chemicals industry's average forecast revenue growth rate of 10.44%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 1,444.25%.

Alto Ingredients's revenue in 2025 is $922,309,000.On average, 4 Wall Street analysts forecast ALTO's revenue for 2025 to be $72,572,003,340, with the lowest ALTO revenue forecast at $68,708,746,065, and the highest ALTO revenue forecast at $75,797,185,090.

In 2026, ALTO is forecast to generate $78,038,570,392 in revenue, with the lowest revenue forecast at $72,309,038,881 and the highest revenue forecast at $83,297,859,576.

What is ALTO's forecast return on assets (ROA) for 2025-2026?

(NASDAQ: ALTO) forecast ROA is -1.02%, which is lower than the forecast US Specialty Chemicals industry average of 9.17%.

What is ALTO's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: ALTO) Alto Ingredients's current Earnings Per Share (EPS) is -$0.69. On average, analysts forecast that ALTO's EPS will be -$0.41 for 2025, with the lowest EPS forecast at -$0.42, and the highest EPS forecast at -$0.39. In 2026, ALTO's EPS is forecast to hit -$0.05 (min: -$0.25, max: $0.17).

What is ALTO's forecast return on equity (ROE) for 2025-2026?

(NASDAQ: ALTO) forecast ROE is -1.77%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.